Risk of advanced-stage breast cancer among older women with comorbidities

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 9, 2012, Pages 1510-1519

  Yasmeen, Shagufta ^a   Hubbard, Rebecca A ^b   Romano, Patrick S ^a   Zhu, Weiwei ^b   Geller, Berta M ^c   Onega, Tracy ^d   Yankaskas, Bonnie C ^e   Miglioretti, Diana L ^b   Kerlikowske, Karla ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d NORRIS COTTON CANCER CENTER   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CANCER STAGING; COMORBIDITY; DISEASE SEVERITY; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICARE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COMORBIDITY; FEMALE; HUMANS; MAMMOGRAPHY; NEOPLASM STAGING; RISK;

EID: 84866164362     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0320     Document Type: Article

References (37)

1. Humphrey LL, Helfand M, Chan BKS, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:347.
2. Ries L, Eisner M, Kosary C. SEER cancer statistics review, 1975-2002. Bethesda, MD: National Cancer Institute. Based on November 2004 SEER data submission, posted to the SEER web site 2005.
3. Kiefe CI, Funkhouser E, Ph D, Fouad MN, May DS. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 1998;13:357-65.
4. Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K. Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care 2005;43:132.
5. Grady KE, Lemkau JP, McVay JM, Reisine ST. The importance of physician encouragement in breast cancer screening of older women*1. Prev Med 1992;21:766-80.
6. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 2007;57:90-104.
7. Yasmeen S, Xing G, Morris C, Chlebowski RT, Romano PS. Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosis. Cancer 2011;117:3252-61.
8. Wyld L, Garg D, Kumar I, Brown H, Reed M. Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines. Br J Cancer 2004;901:486-91.
9. Walter LC, Covinsky KE. Cancer screening in elderly patients. JAMA 2001;285:2750.
10. Holmes CE, Muss HB. Diagnosis and treatment of breast cancer in the elderly. CA Cancer J Clin 2003;53:227-44.
11. Mandelblatt J, Saha S, Teutsch S, Hoerger T, Siu AL, Atkins D, et al. The cost-effectiveness of screening mammography beyond age 65 years. Ann Intern Med 2003;139:835.
12. Fleming ST, Rastogi A, Dmitrienko A, Johnson KD. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care 1999;37:601.
13. Smith-Bindman R, Quale C, Chu PW, Rosenberg R, Kerlikowske K. Can Medicare billing claims data be used to assess mammography utilization among women ages 65 and older? Med Care 2006;44:463.
14. Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg R, Carney PA, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol 1997;169:1001.
15. Kerlikowske K, Walker R, Miglioretti DL, Desai A, Ballard-Barbash R, Buist DSM. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst 2008;100:1724.
16. BCSC Glossary of Terms. Available from: http://breastscreening. cancer.gov/data/bcsc-data-definitions.pdf. 2009Sep16, website.doc accessed May 18, 2012.
17. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002;40:IV-3-18.
18. Smith-Bindman R, Miglioretti DL, Lurie N, Abraham L, Barbash RB, Strzelczyk J, et al. Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med 2006;144:541.
19. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-67.
20. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8.
21. Klabunde CN, Harlan LC, Warren JL. Data sources for measuring comorbidity: a comparison of hospital records and Medicare claims for cancer patients. Med Care 2006;44:921.
22. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 2007;17:584-90.
23. Singletary SE, Connolly JL. Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006;56:37-47.
24. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Tḧurlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003;21:3357.
25. Graubard BI, Korn EL. Predictive margins with survey data. Biometrics 1999;55:652-9.
26. Lane PW, Nelder JA. Analysis of covariance and standardization as instances of prediction. Biometrics 1982;38:613-21.
27. Extermann M. Interaction between comorbidity and cancer. Cancer Control 2007;14:13.
28. Carmichael A, Bates T. Obesity and breast cancer: a review of the literature. Breast 2004;13:85-92.
29. Carmichael A. Obesity and prognosis of breast cancer. Obesity Rev 2006;7:333-40.
30. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta analysis. Int J Cancer 2007;121:856-62.
31. Goodwin PJ, Pritchard KI, Ennis M, Clemons M, Graham M, Fantus IG. Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer 2008;8:501-5.
32. Komninou D, Ayonote A, Richie JP Jr, Rigas B. Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med 2003;228:396.
33. Thomas DR. The relationship between functional status and inflammatory disease in older adults. J Gerontol Ser A 2003;58:M995.
34. Howard DH, Richardson LC, Thorpe KE. Cancer screening and age in the United States and Europe. Health Aff 2009;28:1838.
35. Breen N, Gentleman JF, Schiller JS. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer 2011;117:2209-18.
36. McPherson CP, Swenson KK, Lee MW. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc 2002;50:1061-8.
37. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104.